| 2025 | | Decreased frequency and inflammatory change of FoxP3+ regulatory T cells in immunopathogenesis of human acute graft-versus-host disease
The Korean journal of internal medicine, 40(4). : 657-666, 2025 | 박준성, 양청인, 정성현, 최윤석 |
| 2024 | | Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
The Korean journal of internal medicine, 39(3). : 501-512, 2024 | 정성현, 최윤석 |
| 2023 | | Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study
Molecular cancer, 22(1). : 200-200, 2023 | 정성현, 최윤석 |
| 2023 | | Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
Frontiers in oncology, 13. : 1230629-1230629, 2023 | 정성현, 최윤석 |
| 2023 | | A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea
Expert opinion on biological therapy, 23(8). : 737-747, 2023 | 최윤석 |
| 2023 | | The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma
Biochemical and biophysical research communications, 673. : 36-43, 2023 | 노진, 박준성, 정성현, 최윤석, 한재호 |
| 2023 | | Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts
Cancer research and treatment, 55(1). : 325-333, 2023 | 정성현, 최윤석 |
| 2022 | | Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective Analysis
Anticancer research, 42(12). : 6083-6089, 2022 | 최윤석 |
| 2022 | | Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined with Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma
The American journal of surgical pathology, 46(3). : 289-299, 2022 | 노진, 박준성, 정성현, 최윤석 |
| 2022 | | BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis
Modern pathology, 35(4). : 480-488, 2022 | 노진, 정성현, 최윤석 |
| 2022 | | Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study
Cancer research and treatment, 54(4). : 1268-1277, 2022 | 정성현, 최윤석 |
| 2022 | | POEMS Syndrome: Presented as Idiopathic Multicentric Castleman Disease of Plasma Cell Variant for Eight Years and Dramatic Treatment with Siltuximab Followed by Autologous Peripheral Blood Stem Cell Transplantation
Diagnostics (Basel, Switzerland), 12(4). : 998-998, 2022 | 최윤석 |
| 2021 | | Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia
Annals of hematology, 100(11). : 2825-2830, 2021 | 강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁 |
| 2021 | | Adaptive natural killer cells facilitate effector functions of daratumumab in multiple myeloma
Clinical cancer research, 27(10). : 2947-2958, 2021 | 최윤석 |
| 2021 | | Immuno-oncology for B-cell lymphomas
Blood research, 56(S1). : S70-S74, 2021 | 최윤석 |
| 2020 | | Clinical outcomes of early-progressed follicular lymphoma in Korea: A multicenter, retrospective analysis
Annals of oncology, 31(S6). : S1345-S1345, 2020 | 최윤석 |
| 2020 | | Recent advances in the management of primary central nervous system lymphoma
Blood research, 55(S1). : 58-62, 2020 | 최윤석 |
